Stanniocalcin-1 as a novel marker to detect minimal residual disease of human leukemia

The Tohoku Journal of Experimental Medicine
Yasuo TohmiyaTakeshi Sasaki

Abstract

Stanniocalcin is a glycoprotein hormone that regulates the calcium level in fish. We found that mRNA of human stanniocalcin 1 (STC-1) is detectable in phytohemagglutinin-stimulated T cells and in most human leukemia cell lines, suggesting a role of STC-1 for cell proliferation. This finding prompts us to study the usefulness of STC-1 for monitoring acute leukemia. The levels of STC-1 transcripts increased in patients with acute leukemia at diagnosis and relapse, as judged by quantitative real-time RT-PCR. Levels of transcripts rapidly decreased to within the cut-off levels, when the blast numbers decreased with chemotherapy. Prolonged elevation of STC-1 levels after treatment was associated with a poor prognosis. All of 7 patients relapsed 1 to 4 months after they showed an elevated level of the transcripts in clinical remission. These results indicate that STC-1 is a novel marker for minimal residual disease of acute leukemia, and for an early diagnosis of relapse.

References

Jan 30, 1997·The New England Journal of Medicine·W M RobertsT F Zipf
Nov 29, 1996·Molecular and Cellular Endocrinology·A C ChangR R Reddel
Feb 1, 1997·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·G F WagnerJ L Renfro
Aug 26, 1998·The American Journal of Pathology·K Z ZhangL C Andersson
Jan 9, 1999·Biological & Pharmaceutical Bulletin·Y KoideT Sasaki
Aug 11, 2000·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·W MiuraH Nagura
Apr 12, 2001·British Journal of Haematology·M MatsushitaY Kawakami
Sep 6, 2001·Journal of the National Cancer Institute·A LalG J Riggins
Feb 8, 2002·American Journal of Physiology. Renal Physiology·Kenichi Ishibashi, Masashi Imai
Mar 22, 2002·The Lancet Oncology·T SzczepańskiJ J van Dongen

❮ Previous
Next ❯

Citations

May 21, 2010·Journal of the National Cancer Institute·Guangzhi LiuJinsong Liu
Aug 29, 2009·BMC Structural Biology·Daniel M TrindadeJörg Kobarg
Nov 10, 2011·PloS One·Bonnie H Y Yeung, Chris K C Wong
Jul 25, 2014·Clinical & Experimental Metastasis·Ryosei MuraiNaoki Watanabe
Nov 9, 2015·International Journal of Laboratory Hematology·H M H AbazaH M Mahmoud
Jan 17, 2012·Proteomics·Miroslava Stastna, Jennifer E Van Eyk
Apr 6, 2011·Journal of Cellular Biochemistry·Alice Y S LawChris K C Wong
Nov 19, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yu-Zhen DuFeng Gao
Jul 19, 2015·Molecular and Cellular Endocrinology·Vanessa ScheinRoselis S M da Silva
Nov 26, 2011·Molecular and Cellular Endocrinology·B H Y YeungChris K C Wong
Nov 3, 2010·Molecular BioSystems·Marcos Tadeu dos SantosJörg Kobarg
Nov 14, 2014·Clinical & Experimental Metastasis·Andy C-M ChangRobin L Anderson
Oct 16, 2015·PloS One·Bonnie H Y YeungChris K C Wong
Oct 28, 2010·Molecular Cancer·Wenjing RuanMaode Lai
May 30, 2020·Journal of Cellular and Molecular Medicine·Fangyu ZhaoYupei Zhao
Mar 30, 2021·Molecular Pharmaceutics·Pratheppa RajagopalUma Maheswari Krishnan
Dec 10, 2019·Molecular and Cellular Endocrinology·Bruna Pasqualotto CostaGisele Branchini

❮ Previous
Next ❯

Related Concepts